Bridgewater, N.J.-based Ajanta Pharma USA Inc., a subsidiary of Ajanta Pharma Limited and regular participant of ECRM Pharmacy events, has launched Montelukast Sodium Oral Granules (4mg), a bioequivalent generic version of SINGULAIR Granules, in the US market. Ajanta Pharma offers Montelukast Granules in cartons containing 30 individual sachets.

The approval and launch of the Montelukast Granules is part of an ever-growing portfolio that Ajanta Pharma has developed for the US market. To date, the United States Food & Drug Administration has granted Ajanta Pharma five ANDA final approvals and two ANDA tentative approvals. An additional 19 ANDAs are pending approval from the US FDA.

Ajanta Pharma Limited is a fully-integrated pharmaceutical company with global headquarters in Mumbai, India.